Pharming Group (Netherlands) Volatility
| PHARM Stock | EUR 0.83 0.02 2.35% |
Pharming Group appears to be extremely dangerous, given 3 months investment horizon. Pharming Group NV maintains Sharpe Ratio (i.e., Efficiency) of 0.11, which implies the firm had a 0.11% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Pharming Group NV, which you can use to evaluate the volatility of the company. Please evaluate Pharming Group's Coefficient Of Variation of 950.47, semi deviation of 2.58, and Risk Adjusted Performance of 0.0838 to confirm if our risk estimates are consistent with your expectations. Key indicators related to Pharming Group's volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Pharming Group Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Pharming daily returns, and it is calculated using variance and standard deviation. We also use Pharming's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Pharming Group volatility.
Pharming |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Pharming Group can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Pharming Group at lower prices to lower their average cost per share. Similarly, when the prices of Pharming Group's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving against Pharming Stock
Pharming Group Market Sensitivity And Downside Risk
Pharming Group's beta coefficient measures the volatility of Pharming stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Pharming stock's returns against your selected market. In other words, Pharming Group's beta of 1.19 provides an investor with an approximation of how much risk Pharming Group stock can potentially add to one of your existing portfolios. Pharming Group NV shows above-average downside volatility for the selected time horizon. Pharming Group NV is a potential penny stock. Although Pharming Group may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Pharming Group NV. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Pharming instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Pharming Group NV Demand TrendCheck current 90 days Pharming Group correlation with market (Dow Jones Industrial)Pharming Beta |
Pharming standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 3.3 |
It is essential to understand the difference between upside risk (as represented by Pharming Group's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Pharming Group's daily returns or price. Since the actual investment returns on holding a position in pharming stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Pharming Group.
Pharming Group NV Stock Volatility Analysis
Volatility refers to the frequency at which Pharming Group stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Pharming Group's price changes. Investors will then calculate the volatility of Pharming Group's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Pharming Group's volatility:
Historical Volatility
This type of stock volatility measures Pharming Group's fluctuations based on previous trends. It's commonly used to predict Pharming Group's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Pharming Group's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Pharming Group's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pharming Group NV Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Pharming Group Projected Return Density Against Market
Assuming the 90 days trading horizon the stock has the beta coefficient of 1.1888 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Pharming Group will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pharming Group or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pharming Group's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pharming stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Pharming Group NV has an alpha of 0.2487, implying that it can generate a 0.25 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Pharming Group Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Pharming Group Stock Risk Measures
Assuming the 90 days trading horizon the coefficient of variation of Pharming Group is 935.96. The daily returns are distributed with a variance of 10.88 and standard deviation of 3.3. The mean deviation of Pharming Group NV is currently at 2.36. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.72
α | Alpha over Dow Jones | 0.25 | |
β | Beta against Dow Jones | 1.19 | |
σ | Overall volatility | 3.30 | |
Ir | Information ratio | 0.08 |
Pharming Group Stock Return Volatility
Pharming Group historical daily return volatility represents how much of Pharming Group stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company accepts 3.2981% volatility on return distribution over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7349% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Pharming Group Volatility
Volatility is a rate at which the price of Pharming Group or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Pharming Group may increase or decrease. In other words, similar to Pharming's beta indicator, it measures the risk of Pharming Group and helps estimate the fluctuations that may happen in a short period of time. So if prices of Pharming Group fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Pharming Group N.V., a specialty pharmaceutical company, develops and manufactures biopharmaceutical products in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. PHARMING GROUP operates under Biotechnology classification in Netherlands and is traded on Amsterdam Stock Exchange. It employs 183 people.
Pharming Group's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Pharming Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Pharming Group's price varies over time.
3 ways to utilize Pharming Group's volatility to invest better
Higher Pharming Group's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Pharming Group NV stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Pharming Group NV stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Pharming Group NV investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Pharming Group's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Pharming Group's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Pharming Group Investment Opportunity
Pharming Group NV has a volatility of 3.3 and is 4.52 times more volatile than Dow Jones Industrial. 29 percent of all equities and portfolios are less risky than Pharming Group. You can use Pharming Group NV to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Pharming Group to be traded at €0.7968 in 90 days.Modest diversification
The correlation between Pharming Group NV and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pharming Group NV and DJI in the same portfolio, assuming nothing else is changed.
Pharming Group Additional Risk Indicators
The analysis of Pharming Group's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Pharming Group's investment and either accepting that risk or mitigating it. Along with some common measures of Pharming Group stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0838 | |||
| Market Risk Adjusted Performance | 0.2945 | |||
| Mean Deviation | 2.4 | |||
| Semi Deviation | 2.58 | |||
| Downside Deviation | 3.52 | |||
| Coefficient Of Variation | 950.47 | |||
| Standard Deviation | 3.31 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pharming Group Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Pharming Group as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Pharming Group's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Pharming Group's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Pharming Group NV.
Complementary Tools for Pharming Stock analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |